Results 11 to 20 of about 143,755 (261)

Limited indication of postoperative anticoagulation based on age reduces the incidence of deep venous thrombosis after anterior cruciate ligament reconstruction: A retrospective study [PDF]

Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology
Objective: Deep venous thrombosis (DVT) has the potential to develop into life-threatening pulmonary embolism which is a serious complication after anterior cruciate ligament reconstruction (ACLR). Advanced age (≥40 years) is a known risk factor for DVT.
Masaki Nagashima, Ryo Sasaki, Kentaro Tanaka, Hiroyuki Nagita, Masamitsu Suhara, Mitsuru Yagi   +5 more
doaj   +2 more sources

Regional citrate versus systemic heparin anticoagulation in continuous renal replacement therapy for sepsis-associated acute kidney injury: A retrospective cohort study of short-term outcomes [PDF]

Journal of International Medical Research
Objective To compare the clinical outcomes and prognosis of regional citrate anticoagulation and systemic heparin anticoagulation in patients with sepsis-associated acute kidney injury undergoing continuous renal replacement therapy.
Jian Lan, Yifeng Mao, Chenyang Shi, Qingqing Chen, Shangwen Cai, Xijiang Zhang, Cheng Zheng   +6 more
doaj   +2 more sources

Continuous versus intermittent anticoagulation during endoscopic treatment of esophageal varices in cirrhosis: a randomized controlled trial [PDF]

Therapeutic Advances in Gastroenterology
Background: Endoscopic variceal treatment (EVT) in cirrhotic patients carries a risk of periprocedural bleeding, making anticoagulation management challenging in those with acute portal vein thrombosis (PVT).
Yingying He, Zhihong Wang, Jiayi Zhang, Qianqian Zhang, Yaxian Kuai, Yuchuan Bai, Xuecan Mei, Derun Kong   +7 more
doaj   +2 more sources

Anticoagulants [PDF]

British Medical Bulletin, 2000
Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease.
openaire   +2 more sources

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Research and Practice in Thrombosis and Haemostasis, 2021
Background Coagulopathy has been reported in severely ill patients with coronavirus disease 2019 (COVID‐19). It is unclear whether outpatients with COVID‐19 who are treated with vitamin K antagonists (VKAs) have unstable anticoagulation.
Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition   +6 more
doaj   +1 more source

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

Research and Practice in Thrombosis and Haemostasis, 2022
Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded) by laboratory testing, with the activated partial thromboplastin time and dilute Russell's viper venom time ...
Emmanuel J. Favaloro, Leonardo Pasalic
openaire   +3 more sources

Survival Benefit of Anticoagulation Therapy in End Stage Kidney Disease Patients with Atrial Fibrillation: A Single Center Retrospective Study

Medicina, 2021
Background and Objectives: Although the need for anticoagulation to prevent thromboembolism is increasing and non-vitamin K antagonist oral anticoagulants (NOACs) have been tried, there is still controversy about the efficacy of anticoagulation in ...
Mi-Ryung Kim, Deok-Gie Kim, Han-Wul Shin, Sung-Hwa Kim, Jae-Seok Kim, Jae-Won Yang, Byoung-Geun Han, Seong-Ok Choi, Jun Young Lee   +8 more
doaj   +1 more source

Anticoagulants [PDF]

Journal of Pharmacy and Pharmacology, 1949
Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire   +2 more sources

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry

Open Heart, 2023
Objective There is a substantial incidence of stroke in patients with atrial fibrillation (AF) not receiving anticoagulation. The reasons for not receiving anticoagulation are generally attributed to clinician’s choice, however, a proportion of AF ...
Ajay K Kakkar, Keith A A Fox, Sylvia Haas, Saverio Virdone, Jean-Pierre Bassand, Karen S Pieper, Alexander G G Turpie, Gloria Kayani, Seil Oh, Jörn Nielsen, Frank Cools, John Camm, Marianne Brodmann, Patricia Apenteng, Antonio C P Barretto   +14 more
doaj   +1 more source

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review

Pharmacy, 2016
The purpose of this article is to report a case of fondaparinux outpatient utilization for anticoagulation in a patient with a past medical history of heparin-induced thrombocytopenia (HIT) and discuss the options and need for future anticoagulation ...
Amy Christopher
doaj   +1 more source